Immix Biopharma Eulerpool News

Immix Biopharma Eulerpool News

Immix Biopharma Notizie Azioni

Immix Biopharma è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Immix Biopharma.

• 29 agosto ·

  Yahoo
  Immix Biopharma Independent Director Acquires 2.6% More Stock
• 28 agosto ·

  Yahoo
  Immix Biopharma Expands U.S. Clinical Sites for relapsed/refractory AL Amyloidosis Trial NEXICART-2
• 28 agosto ·

  Thefly.com
  Immix Biopharma announces three more sites for NEXICART-2 trial
• 19 agosto ·

  Yahoo
  What Makes Immix Biopharma (IMMX) a New Buy Stock
• 19 agosto ·

  TipRanks
  Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)
• 12 agosto ·

  InvestorPlace
  IMMX Stock Earnings: Immix Biopharma Beats EPS for Q2 2024
• 26 luglio ·

  TipRanks
  Buy Rating Affirmed: NXC-201’s Promising Clinical Trials and Strategic CIRM Grant Propel Positive Outlook
• 26 luglio ·

  Thefly.com
  Immix Biopharma awarded $8M CLIN2 grant
• 26 luglio ·

  Yahoo
  California Institute for Regenerative Medicine Awards Funding for CAR-T NXC-201 U.S. AL Amyloidosis Clinical Trial (NEXICART-2)
• 8 luglio ·

  Yahoo
  Immix Biopharma Doses 1st Patient in U.S. AL Amyloidosis Trial with CAR-T NXC-201